Oxford Nanopore Technologies plc (ONTTF)
USD 1.8
(-7.69%)
USD 1.8
(-7.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -154.5 Million GBP | -69.74% |
| 2022 | -91.02 Million GBP | 45.69% |
| 2021 | -167.61 Million GBP | -173.68% |
| 2020 | -61.24 Million GBP | 15.19% |
| 2019 | -72.21 Million GBP | -35.95% |
| 2018 | -53.11 Million GBP | 6.04% |
| 2017 | -56.53 Million GBP | 4.34% |
| 2016 | -59.1 Million GBP | -53.47% |
| 2015 | -38.51 Million GBP | -4.16% |
| 2014 | -36.97 Million GBP | -52.69% |
| 2013 | -24.21 Million GBP | -26.39% |
| 2012 | -19.15 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -74.65 Million GBP | 0.0% |
| 2023 Q2 | -70.09 Million GBP | -100.0% |
| 2023 Q3 | -42.2 Million GBP | 39.79% |
| 2023 Q4 | -84.4 Million GBP | -100.0% |
| 2023 FY | -154.5 Million GBP | -69.74% |
| 2023 Q1 | -35.04 Million GBP | 42.4% |
| 2022 Q4 | -60.85 Million GBP | -100.0% |
| 2022 Q1 | -15.08 Million GBP | 87.71% |
| 2022 Q2 | -30.17 Million GBP | -100.0% |
| 2022 Q3 | -30.42 Million GBP | -0.83% |
| 2022 FY | -91.02 Million GBP | 45.69% |
| 2021 Q1 | -22.41 Million GBP | 13.06% |
| 2021 FY | -167.61 Million GBP | -173.68% |
| 2021 Q4 | -122.78 Million GBP | -100.0% |
| 2021 Q2 | -44.83 Million GBP | -100.0% |
| 2021 Q3 | -61.39 Million GBP | -36.94% |
| 2020 Q4 | -25.78 Million GBP | -100.0% |
| 2020 Q1 | -17.73 Million GBP | 0.0% |
| 2020 Q2 | -35.46 Million GBP | -100.0% |
| 2020 Q3 | -12.89 Million GBP | 63.65% |
| 2020 FY | -61.24 Million GBP | 15.19% |
| 2019 FY | -72.21 Million GBP | -35.95% |
| 2018 FY | -53.11 Million GBP | 6.04% |
| 2017 FY | -56.53 Million GBP | 4.34% |
| 2016 FY | -59.1 Million GBP | -53.47% |
| 2015 FY | -38.51 Million GBP | -4.16% |
| 2014 FY | -36.97 Million GBP | -52.69% |
| 2013 FY | -24.21 Million GBP | -26.39% |
| 2012 FY | -19.15 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -106.111% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -2249.519% |
| SQZ Biotechnologies Company | -79.46 Million USD | -94.436% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 391.638% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 337.218% |
| Mesoblast Limited | -87.95 Million USD | -75.664% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -8386.933% |
| Genus plc | 7.9 Million USD | 2055.785% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -1318.57% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -4064.347% |
| Marizyme, Inc. | -65.34 Million USD | -136.441% |
| ContraFect Corporation | -65.15 Million USD | -137.145% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1647.026% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -3062.198% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -8844.198% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -5241.838% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1817.036% |
| MultiCell Technologies, Inc. | -380.07 USD | -40652148.27% |
| Accustem Sciences Inc. | -3.74 Million USD | -4024.125% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -198.899% |
| EV Biologics, Inc. | -1.26 Million USD | -12093.422% |
| Q BioMed Inc. | -2.05 Million USD | -7429.24% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -4038.95% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -24331.577% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -6389.519% |
| Biomind Labs Inc. | -1.21 Million USD | -12623.757% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -1364.799% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1855.019% |
| Skye Bioscience, Inc. | -37.64 Million USD | -310.434% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -7020.749% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -1031597.382% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -2112.668% |
| IMV Inc. | -36.48 Million USD | -323.473% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -873.491% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -2556.013% |
| GB Sciences, Inc. | -1.36 Million USD | -11246.817% |
| Alpha Cognition Inc. | -13.77 Million USD | -1021.846% |
| HST Global, Inc. | -146.21 Thousand USD | -105574.714% |
| CSL Limited | 2.64 Billion USD | 105.848% |
| Halberd Corporation | -79.67 Thousand USD | -193819.122% |
| Enzolytics Inc. | -2.17 Million USD | -6997.792% |
| Resverlogix Corp. | -3.61 Million USD | -4179.972% |
| Affymax, Inc. | -14.42 Million USD | -971.18% |
| SYBLEU INC | -180.3 Thousand USD | -85592.497% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -4771.831% |
| argenx SE | -295.05 Million USD | 47.634% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -146.82% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 157760.204% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -3788.932% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -5005.754% |
| AVAX Technologies, Inc. | -6.41 Million USD | -2309.035% |
| Zenith Capital Corp. | -10.59 Million USD | -1358.163% |
| Genscript Biotech Corporation | -95.47 Million USD | -61.826% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -664674.976% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -3626.71% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -255534.415% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -158.696% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -4881.256% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -14530.555% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -7826.489% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -3945.745% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -7605.643% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1721.376% |
| ONE Bio Corp. | 8.67 Million USD | 1880.73% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -34906.31% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -11469.823% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -8704.967% |
| Agentix Corp. | -1.37 Million USD | -11143.324% |
| LadRx Corporation | 400.44 Thousand USD | 38684.018% |
| Cell Source, Inc. | -5.32 Million USD | -2803.605% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -37087.68% |
| Regen BioPharma, Inc. | 1.02 Million USD | 15195.827% |
| Regen BioPharma, Inc. | 1.02 Million USD | 15195.827% |
| NovAccess Global Inc. | -4.76 Million USD | -3139.693% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 2331.279% |
| Itoco Inc. | -1.86 Million USD | -8166.849% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -3377.902% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -9157.46% |
| Kadimastem Ltd | -3.3 Million USD | -4571.558% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -56412.754% |
| CytoDyn Inc. | -49.84 Million USD | -210.0% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -195396.818% |
| Mobile Lads Corp. | -2.26 Million USD | -6726.649% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -67628.502% |
| Qrons Inc. | -789.34 Thousand USD | -19474.028% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -16310.222% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -7300.888% |
| Rebus Holdings, Inc. | -1.02 Million USD | -15047.745% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -9480.421% |
| International Stem Cell Corporation | -131 Thousand USD | -117844.275% |
| Bioxytran, Inc. | -4.28 Million USD | -3509.975% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -284590.08% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -6006.4% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -221.407% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -7208.751% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -19686.089% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -4777.115% |
| Neutra Corp. | -233.46 Thousand USD | -66079.941% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -661.456% |
| PureTech Health plc | -65.69 Million USD | -135.181% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -626.526% |
| IXICO plc | -1.17 Million USD | -13016.044% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -1456.432% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -170.458% |
| CSL Limited | 2.64 Billion USD | 105.848% |
| Cellectis S.A. | -103.17 Million USD | -49.754% |